Emerging Markets Round Up From JP Morgan Healthcare Conference (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Emerging markets took center stage among Big Pharma presentations at the annual JP Morgan Healthcare Conference in San Francisco last week.
You may also be interested in...
After Running Lilly From China, CEO Says Local Commitment, Innovation Remain Priorities
For almost the entire month of March, Eli Lilly & Co. CEO John Lechleiter ran his company from China, a feat that included hosting Lilly's annual global leadership summit in Shanghai, where 150 high-level Lilly execs gathered to get a firsthand look at the country, visiting hospitals and research centers and meeting with government officials
After Running Lilly From China, CEO Says Local Commitment, Innovation Remain Priorities
For almost the entire month of March, Eli Lilly & Co. CEO John Lechleiter ran his company from China, a feat that included hosting Lilly's annual global leadership summit in Shanghai, where 150 high-level Lilly execs gathered to get a firsthand look at the country, visiting hospitals and research centers and meeting with government officials
Emerging Markets Round Up From JP Morgan Healthcare Conference (Part 2 of 2)
[Editor's note: This is part two of a story carrying highlights on emerging markets from the annual JP Morgan Healthcare Conference in San Francisco last week.